Project Grant R25DK136141

Award Date 9/1/23
Completion Date 4/30/25
Dollars Obligated $514K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Washington, DC, USA
Similar Awards
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $521,237 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Albert Einstein College of Medicine. The grant, titled "Community Health Workers in an Interdisciplinary Outpatient CKD Clinic to Optimize Social Care Navigation, Patient Engagement, and Home Dialysis Utilization- The CHOOSE HOME Trial", will support a pilot randomized trial to...
This federal Project Grant award of $344,632 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will support research to evaluate the impact of recent changes to the kidney allocation system in the United States. The research aims to: (1) assess whether the supply of organs is equitably distributed among U.S. transplant centers under the new 250-nautical-mile kidney...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $154,381 to Dartmouth-Hitchcock Clinic to conduct a training and research program aimed at improving self-advocacy and outcomes for rural residents with chronic kidney disease (CKD). The key products and services to be delivered include: 1) Co-adapting an existing visit agenda-setting...
This $518,661 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to advance the design of hemodialysis cartridges beyond the focus on urea removal. The project will test a novel parallel-plate dialyzer design that controls shear forces to potentially reduce platelet activation and clotting risks for the 548,000 Americans who rely on dialysis. The award to Vanderbilt...
This $577,978 K23 mentored patient-oriented career development award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) will support a research project titled "MOBILIZE: Mobility & Transportation Solutions to Improve Hemodialysis Access". The project aims to: 1) Quantify social risk levels and associations with hemodialysis outcomes in a cohort of 300 patients; 2) Assess the predictive...
The University of California, San Diego, Scripps Research Institute, and San Diego State University are collaborating on a Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $426,769 award will establish a training core to recruit and support 10 outstanding and diverse scholars annually, including at least 2 in hematology research, 2 in urology...
This K01 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program, will provide $155,274 to Emory University to support the career development of Dr. Jeong as an independent clinical and translational investigator in geriatric nephrology. The overarching goals of this research project are to identify neural and vascular mechanisms contributing to accelerated...
This $1,367,059 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund a training program to educate the next generation of diverse leaders in kidney, urology, and hematology (KUH) research. The grant will support 10 pre-doctoral and 24 post-doctoral trainees at the Harvard Kidney, Urology and Hematology Training Institute (HKUHTI), which is...
This K23 Mentored Patient-Oriented Career Development Award from the National Institute of Nursing Research (NINR) under CFDA 93.361 Nursing Research will support the development of an independent research program focused on improving health and quality of life for adults with chronic kidney disease (CKD), particularly in underrepresented minority populations. The $175,618 award, effective July 16, 2024 through May 31, 2027, will fund the adaptation of an evidence-based sedentary reducing...
This $507,163 Project Grant award, funded by the National Institute of Child Health and Human Development (CFDA 93.865 Child Health and Human Development Extramural Research program), will support research to examine the impact of state laws prohibiting disability-based discrimination on equity in kidney transplantation for individuals with intellectual or developmental disabilities (IDD). The key products and services to be delivered under this 5-year grant include: Analyzing national...

DIALYSIS ACCESS JUSTICE, EQUITY, DIVERSITY, INCLUSION (DA-JEDI) PROGRAM. - ABSTRACT ASN IS THE LARGEST NEPHROLOGY SOCIETY IN THE WORLD WITH MORE THAN 21,000 MEMBERS AND A LONGSTANDING COMMITMENT TO JUSTICE, EQUITY, DIVERSITY, AND INCLUSION. WITHIN KIDNEY DISEASE THERE IS A GREAT NEED FOR EQUITY IN DIALYSIS ACCESS (DA). WE PLAN TO SIGNIFICANTLY EXPAND OUR DEI FOOTPRINT IN THIS AREA THROUGH THE DIALYSIS ACCESS- JUSTICE, EQUITY, DIVERSITY AND INCLUSION PROGRAM (DA-JEDI) BY RECRUITING A COHORT OF FELLOWS/EARLY-CAREER FACULTY WHO IDENTIFY AS UNDERREPRESENTED IN MEDICINE (URM). THESE INDIVIDUALS WOULD THEN BE EXPOSED TO A UNIQUE BLEND OF MENTORSHIP, LEADERSHIP, AND SKILL DEVELOPMENT COURSES, WITH A STRONG DA FOCUS, THAT WILL SET THEM ON A PATHWAY TO BECOME CHAMPIONS FOR EQUITABLE, PATIENT-CENTERED DA CARE, AND ALSO FUTURE LEADERS IN ASN AND THE BROADER DIALYSIS ACCESS AND KIDNEY COMMUNITY. WE WILL ACHIEVE THESE GOALS THROUGH FOUR SPECIFIC AIMS. IN SPECIFIC AIM 1 WE WILL RECRUIT A COHORT OF PARTICIPANTS WHO IDENTIFY AS URM INTO DA-JEDI. IN SPECIFIC AIM 2 WE WILL PROVIDE INDIVIDUALIZED DIDACTIC AND EXPERIENTIAL SKILLS TRAINING THROUGH ASN INITIATIVES, THROUGH THE PARTICIPANTS CTSA, OR THOUGH DA-JEDI'S OWN CTSA LINKS. THIS WILL INCLUDE AN ANNUAL DA-JEDI SYMPOSIUM. IN SPECIFIC AIM 3, WE WILL FOSTER UNIQUE MULTI-FACETED MENTORSHIP OPPORTUNITIES, AND FINALLY IN SPECIFIC AIM 4 WE WILL FOCUS ON THE CREATION OF AN ALUMNI NETWORK, PROMOTE NETWORKING OPPORTUNITIES AND DEVELOP AN INTERACTIVE EVALUATION PROCESS WITH A STRONG FEEDBACK LOOP. PUTTING IT ALL TOGETHER, WE STRONGLY BELIEVE THAT GROWING OUR DA-JEDI PARTICIPANTS INTO FUTURE LEADERS FOR ASN, THE KIDNEY COMMUNITY, AND THE DA COMMUNITY, WILL ALLOW US TO BETTER SERVE OUR PATIENTS, WHO DESERVE JUSTICE, EQUITY, DIVERSITY, AND INCLUSION IN BOTH DA AND KIDNEY CARE.

Posted 8/30/23, 12:00 AM